<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Sat, 25 Apr 2026 12:28:30 -0400 -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>    <title>Propanc Biopharma, Inc. (PPCB) News</title>
    <link>https://ir.propanc.com/form-8937/rss</link>
    <description>Propanc Biopharma, Inc. (PPCB) - Form 8937</description>
    <language>en-us</language>
    <generator>Equisolve Investor Relations Suite</generator>
    <item>
      <title><![CDATA[ 2023 Form 8937 ]]></title>
      <description><![CDATA[ <img src="https://content.equisolve.net/propanc/media/ea36a631eee0e055e7d8749b07906f5c.pdf_thumb.jpg" /> ]]></description>
      <link>https://ir.propanc.com/form-8937/view/1/2023-form-8937</link>
      <pubDate>Thu, 25 May 23 01:05:20 -0400</pubDate>
      <guid isPermaLink="true">https://ir.propanc.com/form-8937/view/1/2023-form-8937</guid>
    </item>
  </channel></rss>